Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 33, 2019 - Issue 1
Submit an article Journal homepage
742
Views
2
CrossRef citations to date
0
Altmetric
Articles

Inhibition of Coxsackievirus B3 cardiotropic strain Woodruff replication by silencing essential viral genes

Nikolay PetrovLaboratory of Biology, Department of Natural Sciences, New Bulgarian University, Sofia, Bulgaria; Correspondence[email protected]
View further author information
,
Mariya StoyanovaLaboratory of Molecular Biology, Institute of Soil Science, Agrotechnologies and Plant Protection ‘Nikola Pushkarov’, Agricultural Academy, Sofia, Bulgaria; View further author information
&
Angel GalabovDepartment of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, BulgariaView further author information
Pages 1582-1589 | Received 18 Aug 2019, Accepted 10 Oct 2019, Published online: 29 Oct 2019

References

  • Tam PE, Messner RP. Molecular mechanisms of Coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol. 1999;73(12):10113–10121.
  • Li-Sha G, Li L, De-Pu Z, et al. Ivabradine treatment reduces cardiomyocyte apoptosis in a murine model of chronic viral myocarditis. Front Pharmacol. 2018;9:182. doi:10.3389/fphar.2018.00182
  • Jiang D, Li M, Yu Y, et al. microRNA-34a aggravates Coxsackievirus B3-induced apoptosis of cardiomyocytes through the SIRT1-p53 pathway. J Med Virol. 2019;91(9):1643–1651. doi:10.1002/jmv.25482
  • Peischard S, Ho HT, Theiss C, et al. A kidnapping story: how Coxsackievirus B3 and its host cell interact. Cell Physiol Biochem. 2019;53(1):121–140. doi:10.33594/000000125
  • Zhang Z, Long C, Li X, et al. CEACAM-1 promotes myocardial injury following Coxsackievirus infection by regulating the Coxsackievirus-adenovirus receptor. Medicine (Baltimore). 2019;98(19):e15629. doi:10.1097%2FMD.0000000000015629
  • McManus BM, Chow LH, Wilson JE, et al. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol. 1993;68(2):159–169.
  • Huber SA. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab Invest. 1997;76(5):691–701.
  • Pappritz K, Savvatis K, Miteva K, et al. Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis. FASEB J. 2018;32(11):6066–6078.
  • Merl S, Michaelis C, Jaschke B, et al. Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation. 2005;111(13):1583–1592.
  • Yuan J, Cheung PK, Zhang HM, et al. Inhibition of Coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J Virol. 2005;79(4):2151–2159.
  • Ahn J, Jun ES, Lee HS, Yoon SY, Kim D, et al. A small interfering RNA targeting Coxsackievirus B3 protects permissive HeLa cells from viral challenge. J Virol. 2005;79(13):8620–8624.
  • Petrov N, Galabov A. Influence of specific siRNAs on the replication of Coxsackieviruses. In: Galabov AS, Angelova M, Najdenski H, editors. Proceedings of the Third congress of Virology (Days of virology in Bulgaria) with international participation; 2012 Oct 25–27; Sofia, Bulgaria. Sofia: Press Product Line; 2012. p. 21–25.
  • Werk D, Schubert S, Lindig V, et al. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of Coxsackievirus B3 and its cognate Coxsackievirus-adenovirus receptor. Biol Chem. 2005;386(9):857–863.
  • Schubert S, Rothe D, Werk D, et al. Strand-specific silencing of a picornavirus by RNA interference: evidence for the superiority of plus-strand specific siRNAs. Antivir Res. 2007;73(3):197–205.
  • Schubert S, Grunweller A, Erdmann VA, et al. Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J Mol Biol. 2005;348(4):883–893.
  • Petrov N, Galabov A. Conserved regions from Coxsackievirus genome as targets for gene silencing (RNAi). Sci Technol. 2012;II(1):32–36.
  • Petrov N, Galabov A. Small Interfering RNAs against human enteroviral infections. Acta Microbiol Bulg. 2016;32(2):101–107.
  • Rott ME, Jelkmann W. Characterization and detection of several filamentous viruses of cherry: adaptation of an alternative cloning method (DOP-PCR) and modification of an RNA extraction protocol. Eur J Plant Pathol. 2001;107(4):411–420.
  • Borenfreund E, Puerner JA. A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90). Methods Cell Sci. 1985;9:7–9.
  • Petrov N, Bamford D, Galabov A. Production of dsRNAs for induction of posttranscriptional gene silencing against Coxsackievirus B1 infection. Sci Technol. 2011;1(1):255–258.
  • Fechner H, Pinkert S, Wang X, Sipo I, et al. Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther. 2007;14(12):960–971.
  • Sharma M, Mishra B, Saikia UN, et al. Inhibition of Coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate Coxsackievirus adenovirus receptor. Indian J Med Res. 2017;146(4):520–527.
  • Meyer IS, Goetzke CC, Kespohl M, et al. Silencing the CSF-1 axis using nanoparticle encapsulated siRNA mitigates viral and autoimmune myocarditis. Front Immunol. 2018;9 2303. doi:10.3389/fimmu.2018.02303
  • Mishra AK, Satpathy G. Inhibition of Coxsackievirus A24 in permissive Hep2 cells by small interfering RNA (siRNA). IOSRJPBS. 2017;12(03):21–26.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.